HELLS and lung carcinoma: Of note, some chromatic remodeling factors, including lymphoid-specific helicase (LSH), have been validated to play pivotal roles in the tumor progression and prognosis of multiple cancers, including gliomas [75, 76], lung cancer [77–79] and nasopharyngeal carcinoma [80].